TNF and obesity due to melanocortin 4 receptor deficiency: Some studies suggested that obese patients with CD had a reduced risk of penetrating disease, hospitalizations, CD-related surgery and the need for anti-TNF therapy while others, such as Greuter et al., found obesity to be associated with an increased risk of complications and decreased remission [35,36].